At the same time, gross spending increased ninefold, from about $1 billion in 2019 to almost $9 billion in 2024, and gross spending per GLP-1 prescription reached $1,000 in 2024
PBMs also set the utilization controls that help balance access and affordability, such as prior authorization, step therapy, and BMI or diagnosis requirements for weight-management use
Available from: Johansen PB, Nowak J, Skjrbk C, et al
Tailored for Excellence: VIOSs Commitment to Quality and Safety At VIOS, quality and safety are paramount
With this approval, and by launching a generic for Saxenda (liraglutide injection), we will provide patients in the U.S
Normal blood levels of calcium are maintained even when dietary intake of calcium is inadequate because the skeleton provides a large reserve of the mineral